Vertex Pharmaceuticals IncorporatedVRTX

Where VRTX's P/E ratio sits inside its own 10-year distribution, with the yearly high, low and average.

$515.44+0.88 (+0.17%)Previous close
NASDAQHealthcare

VRTX P/E ratio: current value, 10-year range and year-by-year history

30.0Above average

VRTX's p/e ratio is higher than 65% of the last 10 years.

P/E ratio History

Historically priceyAbove avgAround avgBelow avgHistorically cheap
VRTX P/E ratio historyVRTX P/E ratio from Sep 2023 to Sep 2026: low -259.67, high 34.28, latest 30.-283.18-197.94-112.7-27.4557.79Sep 23Apr 24Nov 24Jul 25Feb 26Sep 26med 27.18

VRTX P/E ratio by year

Yearly range of VRTX’s p/e ratio from 2016 to 2026. Over the full period it ranged from -259.7 to 199.4, averaging 17.2.

VRTX P/E ratio — yearly low, average, high and year-end values
YearLowAverageHighYear-end
202625.128.732.630.0
2025-233.5-63.634.329.6
2024-259.7-104.832.1-183.0
202322.126.230.830.5
202222.125.430.822.8
202117.922.626.824.3
202020.238.554.922.9
201919.522.448.548.5
201820.5129.5197.620.5
2017-229.883.5199.4192.1
2016-104.8-87.9-75.2-81.0

Get notified when VRTX P/E ratio crosses a threshold

Free — one alert setup, notifications by push, Telegram, or Discord.

How much the market pays for each dollar of annual profit. P/E = Stock Price / EPS. The raw number means little — what matters is whether it's high or low relative to the company's own history.

FormulaPrice / Earnings Per Share
Full guide
How to read this chart

The chart shows five color-coded historical zones: green (below 10th percentile) means historically very cheap, fading through lime and gray (the normal 25th–75th range) to orange and red (historically expensive). When the line sits in a green or lime zone, the stock is trading at an unusually low P/E relative to its own history.

Key caveats
  • Cyclical businesses look cheapest on P/E at peak earnings — the "earnings trap." Use EV/EBITDA or normalised earnings for energy, materials, and financials.
  • A falling P/E trend may signal a business in structural decline, not a buying opportunity.

Is VRTX P/E ratio High or Low Right Now?

Vertex Pharmaceuticals Incorporated's P/E ratio is currently 30.0, which is above average relative to its 10-year historical range. The 10-year median P/E ratio for VRTX is approximately 26.4. See all VRTX valuation metrics →

Pro — up to 30-year history

Unlock 10y, 15y, 20y, and 30y history with peer comparison and CSV export.